ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,294Medicare Part D Prescriptions Filled, Including Refills

Rank: 52 out of 680

$1.19M Total Retail Price of All Prescriptions

Rank: 46 out of 680

721 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 721 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

14% of this provider’s 721 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 17,089 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LEVOTHYROXINE SODIUM 755 681 1 2
SIMVASTATIN 666 601 2 3
FUROSEMIDE 611 571 3 6
LISINOPRIL 569 502 4 5
AMLODIPINE BESYLATE 493 447 5 1
OMEPRAZOLE 421 367 6 7
HYDROCODONE-ACETAMINOPHEN 379 294 S3 7 4
METOPROLOL TARTRATE 353 326 8 12
METOPROLOL SUCCINATE 330 326 9 13
PRAVASTATIN SODIUM 309 299 10 10
GABAPENTIN 277 235 11 15
HYDROCHLOROTHIAZIDE 274 252 12 9
POTASSIUM CHLORIDE 274 228 12 14
NAMENDA 265 265 14 35
CARVEDILOL 238 211 15 23
TRAMADOL HCL 231 172 16 18
SERTRALINE HCL 230 184 17 28
METFORMIN HCL 218 190 18 8
CYMBALTA 215 196 19 46
PANTOPRAZOLE SODIUM 210 204 20 30
POLYETHYLENE GLYCOL 3350 200 194 21 62
LOSARTAN POTASSIUM 198 190 22 21
PAROXETINE HCL 191 165 23 76
WARFARIN SODIUM 189 181 24 20
ZOLPIDEM TARTRATE 182 135 25 17
NEXIUM 174 134 26 16
MELOXICAM 172 140 27 24
DONEPEZIL HCL 167 158 28 27
CITALOPRAM HBR 165 156 29 22
ATORVASTATIN CALCIUM 164 152 30 11
RISPERIDONE 155 152 31 80
DIGOXIN 153 149 32 58
TRAZODONE HCL 146 122 33 48
TAMSULOSIN HCL 142 137 34 34
CLOPIDOGREL 142 136 34 26
PLAVIX 141 134 36 39
ESCITALOPRAM OXALATE 131 121 37 45
GLIMEPIRIDE 128 76 38 29
QUETIAPINE FUMARATE 124 124 39 64
ALLOPURINOL 121 121 40 33
DIOVAN 120 112 41 31
MIRTAZAPINE 117 100 42 78
ATENOLOL 116 84 43 19
LYRICA 114 93 44 77
CLONIDINE HCL 112 105 45 36
ISOSORBIDE MONONITRATE ER 107 97 46 59
PREDNISONE 107 101 46 50
KLOR-CON M20 106 105 48 61
CRESTOR 105 89 49 25
ALENDRONATE SODIUM 103 95 50 32
AMITRIPTYLINE HCL 94 83 R 51 47
NOVOLOG FLEXPEN 93 75 52 189
LEVEMIR FLEXPEN 91 81 53 186
BENICAR 91 88 53 131
SYNTHROID 88 88 55 38
NIFEDIPINE ER 85 73 56 75
JANUVIA 83 78 57 60
SINGULAIR 82 67 58 91
HYDRALAZINE HCL 81 69 59 71
CEFUROXIME 80 70 60 179
CELEBREX 79 79 61 90
FLUTICASONE PROPIONATE 79 74 61 41
FAMOTIDINE 76 58 63 89
WELCHOL 75 71 64 223
AZITHROMYCIN 73 55 65 42
BUPROPION HCL SR 67 55 66 250
LANTUS 65 59 67 49
ADVAIR DISKUS 63 36 68 53
NOVOFINE AUTOCOVER 63 55 68 248
JANUMET 62 48 70 194
SOTALOL 60 60 71 226
NITROFURANTOIN 60 60 71 269
LEVOFLOXACIN 59 52 73 97
HUMALOG 59 48 73 196
DILTIAZEM 24HR ER 59 48 73 132
MONTELUKAST SODIUM 58 47 76 157
VYTORIN 57 56 77 152
AGGRENOX 57 56 77 177
LEXAPRO 55 51 79 128
OXYBUTYNIN CHLORIDE 55 45 79 129
BUPROPION XL 54 52 81 161
SEROQUEL 53 53 82 123
METOCLOPRAMIDE HCL 52 40 83 118
CIPROFLOXACIN HCL 52 48 83 57
ZETIA 51 42 85 87
HUMULIN N 51 42 85 246
PROAIR HFA 51 23 85 67
GLYBURIDE 50 41 R 88 85
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 20, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.